1. FRI0320 Lesinurad, A Selective URIC Acid Reabsorption Inhibitor, in Combination with Allopurinol: Results from a Phase III Study in Gout Patients Having an Inadequate Response to Standard of Care (Clear 1). (9th June 2015) Authors: Saag, K.; Fitz-Patrick, D.; Kopicko, J.; Fung, M.; Bhakta, N.; Adler, S.; Storgard, C.; Baumgartner, S.; Becker, M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 540 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0333 Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination with Allopurinol: Results from a Phase III Study in Gout Patients Having an Inadequate Response to Standard of Care (Clear 2). (9th June 2015) Authors: Bardin, T.; Keenan, R.; Khanna, P.; Kopicko, J.; Fung, M.; Bhakta, N.; Adler, S.; Storgard, C.; Baumgartner, S.; So, A. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 545 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0343 Evaluation of the Impact of Current Treatment on Serum Urate Profile, Gout Flares and Tophi in Patients with Gout in France, Germany, United Kingdom and the United States. (9th June 2015) Authors: Nuevo, J.; Nyberg, F.; Horne, L.; Morlock, R.; Storgard, C.; Aiyer, L.; Hines, D.M.; Ansolabehere, X.; Chevalier, P. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 549 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0350 Evaluation of Cardiovascular and Renal Morbidity in Patients with Gout in Germany, United Kingdom, United States, and France: The International Comorbidity and Resource Utilization Study of Gout (ICARUS). (9th June 2015) Authors: Nuevo, J.; Nyberg, F.; Horne, L.; Morlock, R.; Storgard, C.; Aiyer, L.; Hines, D.; Ansolabehere, X.; Chevalier, P. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 552 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SAT0307 Lesinurad Monotherapy in Gout Patients Intolerant to Xanthine Oxidase Inhibitors (Light): A Randomized, Double-Blind, Placebo-Controlled, 6-Month Phase III Clinical Trial. (9th June 2015) Authors: Tausche, A.-K.; Alten, R.; Dalbeth, N.; Kopicko, J.; Bhakta, N.; Storgard, C.; Baumgartner, S.; Saag, K. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 769 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SAT0313 Relationship Between Sustained Lowering of Serum Urate Levels and Improvements in Gout Flares and Tophus Area: Pooled Exploratory Analysis of Gout Subjects Receiving Lesinurad and Xanthine Oxidase Inhibitor Combination Therapy. (9th June 2015) Authors: Terkeltaub, R.; Perez-Ruiz, F.; Storgard, C.; Fung, M.; Kopicko, J.; Dalbeth, N. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 771 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SAT0329 Lesinurad, A Novel Selective Uric Acid Reabsorption Inhibitor, in Combination with Febuxostat, in Patients with Tophaceous Gout: the Crystal Phase III Clinical Trial. (9th June 2015) Authors: Dalbeth, N.; Jones, G.; Terkeltaub, R.; Khanna, D.; Kopicko, J.; Bhakta, N.; Fung, M.; Storgard, C.; Baumgartner, S.; Perez-Ruiz, F. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 778 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SAT0383 High Dose Allopurinol in France, Germany, Italy, Spain and the UK. (23rd January 2014) Authors: Singh, J. A.; Storgard, C.; Baumgartner, S.; Morlock, R. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A713 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. SAT0384 Patients that Continue to Flare Despite Reaching Eular/ ACR Recommended Serum Urate Target. (23rd January 2014) Authors: Khanna, D.; Khanna, P. P.; Storgard, C.; Baumgartner, S.; Morlock, R. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A713 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. SAT0554 Assessing SUA, Flare Rates, and Tophi in Patients with Gout Treated Xanthine Oxidase Inhibitors in the United States. (23rd January 2014) Authors: Khanna, P. P.; Baumgartner, S.; Khanna, D.; Storgard, C.; Morlock, R. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A770 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗